Global Cardiovascular Diagnostics Market 2018-2024 with Abbott Laboratories, GE Healthcare, Philips Healthcare, Roche Diagnostics, and Bayer Healthcare Dominating - ResearchAndMarkets.com

DUBLIN--()--The "Global Cardiovascular Diagnostics market and Drivers, Restraints, and Opportunities 2018-2024" report has been added to ResearchAndMarkets.com's offering.

The global cardiovascular diagnostics market is estimated to witness a CAGR of 8.5% during the forecast period 2018-2024

The cardiovascular diagnostics market is growing at a steady pace and is expected to grow at a rapid rate in the emerging countries. Factors, such as increasing lifestyle diseases, rise in smoking population, growing aging population, favorable reimbursements, and technological advancements in products, are driving the growth of the cardiovascular diagnostics market. However, the lack of awareness about diseases, stringent regulatory approval procedures, and risks associated with the procedure are hampering the market growth. The primary unmet need in the market is endoleaking, which increases the mortality rate.

The market is dominated by Abbott Laboratories, GE Healthcare, Philips Healthcare, Roche Diagnostics, and Bayer Healthcare, which have more than 85% of the share in the global cardiovascular diagnostics market.

Abbott Laboratories, GE Healthcare, Philips Healthcare, Roche, Bayer Healthcare, and other predominate & niche players.

Market Dynamics

Drivers

  • Increasing prevalence of cardiovascular diseases
  • Increasing geriatric population
  • Growing acceptance for minimally invasive endovascular surgeries
  • Increasing awareness towards point of care diagnostics in developing countries
  • Increase in healthcare spending

Restraints

  • High cost in installation and upgradation
  • Stringent regulations for approval
  • Intense competition among vendors
  • Lack of skilled healthcare professionals
  • Availability of alternative treatment procedure

Opportunities

  • Increase in demand for cardiac diagnostic imaging
  • Emergence of mHealth for improved outcome
  • Market expansion opportunities in emerging nations
  • Increasing number of insurance providers

Key Topics Covered:

1. Industry Outlook

2. Report Outline

3. Market Snapshot

4. Market Dynamics

5. Product Types: Market Size & Analysis

6. End-user: Market Size and Analysis

7. Regions: Market Size & Analysis

8. Competitive Landscape

9. Vendor Profiles

  • Abbott Laboratories
  • F.Hoffmann-La Roche Ltd
  • GE Healthcare
  • Philips Healthcare
  • Siemens Healthineers Inc. (Siemens AG)

10. Companies to watch for

  • Medtronic Plc
  • Hill-Rom Holdings, Inc
  • Qiagen N.V.
  • Boston Scientific Corp
  • Instrumentation Laboratory (a Werfen company)
  • Becton Dickinson and Company

For more information about this report visit https://www.researchandmarkets.com/research/npnrxv/global?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Diagnostics

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Diagnostics